News Headline Summary

Wedbush maintains Sarepta Therapeutics (SRPT) with a outperform and lowers the price target from USD 70.00 to USD 60.00

Reaction details (18:08)

- Co. shares are unmoved by this latest broker move; trades USD 24.28 last (-1.7%).

17 Jan 2013 - 18:06 - Equities - Source: RANsquawk

Subscribe Now to RANsquawk

Click here for a 1 week free trial

RANsquawk provides audio news and commentary for over 15,000 professional traders and brokers worldwide. Services include: